Cogent Biosciences, Inc. (COGT) Social Stream



Cogent Biosciences, Inc. (COGT): $3.99

-0.07 (-1.72%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add COGT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 388

in industry

Cogent Biosciences Inc (COGT) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Cogent Biosciences Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-11 7 $31 $15 $21.428 $8.29 158.48%
2022-02-08 7 $31 $14 $20.571 $8.29 148.14%
2022-03-16 7 $31 $14 $20.714 $8.29 149.87%

The Trend in the Analyst Price Target


COGT's average price target has moved down $0.24 over the prior 52 weeks.

COGT reports an average of 165.91% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-17 4 24 15 20.670 8.50 143.18%
2021-08-01 4 24 15 20.830 6.00 247.17%
2021-09-04 4 24 15 19.830 8.24 140.66%
2021-09-18 4 24 15 19.830 8.99 120.58%
2022-02-08 7 31 14 20.571 7.19 186.11%

COGT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 7 0 0 0 0 7

The Trend in the Broker Recommendations


COGT's average broker recommendation rating improved by 0.33 over the prior 151 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for COGT as an investment opportunity.

  • Cogent Biosciences Inc's variance in analysts' estimates is lower than -246.12% of all US stocks.
  • In the context of all US stocks, Cogent Biosciences Inc's upside potential (average analyst target price relative to current price) is greater than 339.54% of them.
  • In the context of all US stocks, Cogent Biosciences Inc's average analyst price target is higher than 95.59% of them.
  • In the context of stocks in the small market cap category, Cogent Biosciences Inc's number of analysts covering the stock is greater than 345.48% of them.

Stocks similar to Cogent Biosciences Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CNTB, CNTA, and CNCE.

Make investment decisions regarding COGT using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.9097 seconds.